A detailed history of State Of Alaska, Department Of Revenue transactions in Eli Lilly & CO stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 99,104 shares of LLY stock, worth $74.1 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
99,104
Previous 99,344 0.24%
Holding current value
$74.1 Million
Previous $89.9 Million 2.38%
% of portfolio
0.93%
Previous 1.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $185,313 - $230,404
-240 Reduced 0.24%
99,104 $87.8 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $4.08 Million - $5.12 Million
-5,630 Reduced 5.36%
99,344 $89.9 Million
Q1 2024

Apr 19, 2024

SELL
$592.2 - $792.28 $2.61 Million - $3.49 Million
-4,400 Reduced 4.02%
104,974 $81.7 Million
Q4 2023

Jan 19, 2024

SELL
$525.19 - $619.13 $3.67 Million - $4.33 Million
-6,990 Reduced 6.01%
109,374 $63.8 Million
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $1.22 Million - $1.68 Million
-2,810 Reduced 2.36%
116,364 $62.5 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $7.77 Million - $10.4 Million
-22,147 Reduced 15.67%
119,174 $55.9 Million
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $492,348 - $578,239
-1,585 Reduced 1.11%
141,321 $48.5 Million
Q4 2022

Jan 11, 2023

BUY
$321.55 - $374.67 $92,284 - $107,530
287 Added 0.2%
142,906 $52.3 Million
Q3 2022

Oct 20, 2022

SELL
$296.48 - $337.87 $2.32 Million - $2.65 Million
-7,834 Reduced 5.21%
142,619 $46.1 Million
Q2 2022

Jul 08, 2022

SELL
$278.73 - $327.27 $19.2 Million - $22.5 Million
-68,844 Reduced 31.39%
150,453 $48.8 Million
Q1 2022

Apr 14, 2022

SELL
$234.69 - $291.66 $2.72 Million - $3.37 Million
-11,571 Reduced 5.01%
219,297 $62.8 Million
Q4 2021

Jan 12, 2022

SELL
$224.85 - $279.04 $4.36 Million - $5.41 Million
-19,385 Reduced 7.75%
230,868 $63.8 Million
Q3 2021

Oct 07, 2021

SELL
$221.6 - $272.71 $92,850 - $114,265
-419 Reduced 0.17%
250,253 $57.8 Million
Q2 2021

Jul 12, 2021

SELL
$180.55 - $233.54 $7.39 Million - $9.56 Million
-40,917 Reduced 14.03%
250,672 $57.5 Million
Q1 2021

Apr 09, 2021

SELL
$164.32 - $212.72 $3.21 Million - $4.15 Million
-19,519 Reduced 6.27%
291,589 $54.5 Million
Q4 2020

Jan 08, 2021

SELL
$130.46 - $172.63 $2.01 Million - $2.66 Million
-15,415 Reduced 4.72%
311,108 $52.5 Million
Q3 2020

Oct 05, 2020

BUY
$146.22 - $169.13 $19.1 Million - $22.1 Million
130,879 Added 66.9%
326,523 $48.3 Million
Q2 2020

Jul 06, 2020

BUY
$136.42 - $164.18 $4.48 Million - $5.39 Million
32,849 Added 20.18%
195,644 $32.1 Million
Q1 2020

Apr 06, 2020

BUY
$119.05 - $147.35 $961,209 - $1.19 Million
8,074 Added 5.22%
162,795 $22.6 Million
Q4 2019

Jan 07, 2020

SELL
$106.92 - $132.43 $3.01 Million - $3.73 Million
-28,169 Reduced 15.4%
154,721 $20.3 Million
Q3 2019

Oct 02, 2019

BUY
$106.79 - $116.16 $6.4 Million - $6.96 Million
59,910 Added 48.72%
182,890 $20.5 Million
Q2 2019

Jul 23, 2019

BUY
$110.79 - $129.32 $68,135 - $79,531
615 Added 0.5%
122,980 $13.6 Million
Q1 2019

Apr 09, 2019

SELL
$111.31 - $131.02 $9.14 Million - $10.8 Million
-82,122 Reduced 40.16%
122,365 $15.9 Million
Q4 2018

Jan 10, 2019

BUY
$105.9 - $118.64 $685,596 - $768,075
6,474 Added 3.27%
204,487 $23.7 Million
Q3 2018

Oct 09, 2018

SELL
$85.86 - $107.31 $503,397 - $629,158
-5,863 Reduced 2.88%
198,013 $21.2 Million
Q2 2018

Jul 10, 2018

SELL
$75.7 - $86.88 $981,072 - $1.13 Million
-12,960 Reduced 5.98%
203,876 $17.4 Million
Q1 2018

Apr 19, 2018

BUY
$74.21 - $87.6 $3 Million - $3.55 Million
40,480 Added 22.95%
216,836 $16.8 Million
Q4 2017

Jan 19, 2018

BUY
$81.94 - $87.89 $8.01 Million - $8.59 Million
97,741 Added 124.33%
176,356 $14.9 Million
Q3 2017

Oct 16, 2017

BUY
$77.07 - $85.54 $6.06 Million - $6.72 Million
78,615
78,615 $6.72 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.